Publications by authors named "Christopher R Garrett"

Claim this Profile
V
Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Amal Al Omari, Hadeel Abdelkhaleq, Maysa Al-Hussaini, Rim Turfa, Nour Awad, Christopher R Garrett

J Glob Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of RET fusions in advanced colorectal cancer.
Anne-France Le Rolle, Samuel J Klempner, Christopher R Garrett, Tara Seery, Eric M Sanford

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer.
J Randolph Hecht, Tony R Reid, Christopher R Garrett, J Thaddeus Beck, Sheldon J Davidson

Anticancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity in RAS-driven tumors by blocking AKT and MEK.
Anthony W Tolcher, Khurum Khan, Michael Ong, Udai Banerji, Vassiliki Papadimitrakopoulou, Christopher R Garrett

Clin Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.
Ibrahim Halil Sahin, Manal M Hassan, Christopher R Garrett

Cancer Lett· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.
Prajnan Das, Cathy Eng, Miguel A Rodriguez-Bigas, George J Chang, John M Skibber, Christopher R Garrett

Int J Radiat Oncol Biol Phys· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study.
Suebpong Tanasanvimon, Naveen Garg, Chitra Viswanathan, Mylene Truong, Harmeet Kaur, Christopher R Garrett

Thromb Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.
Christopher R Garrett, Tanios S Bekaii-Saab, Theresa Ryan, George A Fisher, Sally Clive

Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.
Ibrahim Halil Sahin, Syed M A Kazmi, Jeffrey T Yorio, Nishin A Bhadkamkar, Bryan K Kee, Christopher R Garrett

J Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin use and improved response to therapy in rectal cancer.
Heath D Skinner, Christopher H Crane, Christopher R Garrett, Cathy Eng, George J Chang

Cancer Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary.
Christopher R Garrett, Ben George, Chitra Viswanathan, Nishin A Bhadkamkar, Sijin Wen

Clin Colorectal Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.
Jeffrey T Yorio, Nishin A Bhadkamkar, Bryan K Kee, Christopher R Garrett

Int J Surg Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure.
George D Demetri, Christopher R Garrett, Patrick Schöffski, Manisha H Shah, Jaap Verweij

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT.
Christopher R Garrett, Domenico Coppola, Robert M Wenham, Christopher L Cubitt, Anthony M Neuger

Invest New Drugs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
Antoine Brouquet, Michael J Overman, Scott Kopetz, Dipen M Maru, Evelyne M Loyer, Christopher R Garrett

Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab in the treatment of patients with colorectal cancer.
Christopher R Garrett, Cathy Eng

Expert Opin Biol Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
Antoine Brouquet, Eddie K Abdalla, Scott Kopetz, Christopher R Garrett, Michael J Overman

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation to the abdomen for gastrointestinal malignancies.
Waqar Haque, Christopher H Crane, Sunil Krishnan, Marc E Delclos, Milind Javle, Christopher R Garrett

Radiat Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.
Samuel E Deprimo, Xin Huang, Martin E Blackstein, Christopher R Garrett, Charles S Harmon

Clin Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab.
Daanish Hoda, George R Simon, Christopher R Garrett

Ther Clin Risk Manag· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.
Anthony W Tolcher, Alain Mita, Lionel D Lewis, Christopher R Garrett, Elizabeth Till

J Clin Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
José Cangiano, Barbara A Centeno, Christopher R Garrett, William Cáceres, Ana de Jesús

Dig Dis Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia.
Elizabeth Sagatys, Christopher R Garrett, David Boulware, Scott Kelley, Mokenge Malafa

Hum Pathol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia.
Ozlen Saglam, Christopher R Garrett, David Boulware, Zena Sayegh, David Shibata

Clin Colorectal Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
Shirin Khambata-Ford, Christopher R Garrett, Neal J Meropol, Mark Basik, Christopher T Harbison

J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis